Zobrazeno 1 - 10
of 246
pro vyhledávání: '"Patrick M Forde"'
Autor:
Keith M Kerr, Elizabeth Thompson, Mariano Provencio, Patrick M Forde, Jaclyn Neely, Ashley Cimino-Mathews, Ludmila Danilova, Daphne Wang, Robert A Anders, Tricia R Cottrell, Nicolas Girard, Janis Taube, Peter Illei, Junliang Cai, Joel Sunshine, Julie Stein Deutsch, Jonathan Spicer, Edward Gabrielson, Jaroslaw Jedrych, Mia Tran, Judy Bushong, Vipul Devas, David Balli, Alex S Baras
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 2 (2023)
Externí odkaz:
https://doaj.org/article/b726db52c75b450c81413c801ce2dbf2
Autor:
Laura C Cappelli, Patrick M Forde, Ami A Shah, Julie Brahmer, Joseph C Murray, Paola Ghanem, Vincent K Lam, Benjamin P Levy, Kristen A Marrone, Susan C Scott, Josephine L Feliciano, Christine L Hann, David S Ettinger, Christopher Mecoli
Publikováno v:
RMD Open, Vol 9, Iss 4 (2023)
Purpose Concomitant autoimmune rheumatic diseases (ARD) can add morbidity and complicate treatment decisions for patients with lung cancer. We evaluated the tumour characteristics at diagnosis and clinical outcomes in lung cancer patients with or wit
Externí odkaz:
https://doaj.org/article/0a0d1f66575040e49d7c3c68700e07dc
Autor:
Julie R Brahmer, Patrick M Forde, Jarushka Naidoo, Valsamo Anagnostou, Cheng Ting Lin, Peter B Illei, Kellie N Smith, Mara Lanis, Khinh Ranh Voong, Bradley Presson, Dipika Singh, Zhen Zeng, Russell K Hales, Phuoc T Tran, Christos Georgiades, Jeffrey Thiboutout
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 10 (2023)
Stereotactic ablative body radiation (SABR) delivers high rates of local control in early-stage non-small cell lung cancer (NSCLC); however, systemic immune effects are poorly understood. Here, we evaluate the early pathologic and immunologic effects
Externí odkaz:
https://doaj.org/article/73057316b1824f259f171d6d18eefaee
Autor:
Patrick M Forde, Dhiraj Kumar, Steven P Rowe, Lilja B Solnes, Ajay Kumar Sharma, Akhilesh Mishra, Kuldeep Gupta, Gabriela Lofland, Martin G Pomper, Edward W Gabrielson, Sridhar Nimmagadda
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 10 (2023)
Background Combination therapies that aim to improve the clinical efficacy to immune checkpoint inhibitors have led to the need for non-invasive and early pharmacodynamic biomarkers. Positron emission tomography (PET) is a promising non-invasive appr
Externí odkaz:
https://doaj.org/article/7856009de17747f48b0f6f8e7f6db401
Autor:
Tian Zhang, Patrick M Forde, Elad Sharon, Scot Ebbinghaus, Michael B Atkins, Mark Stewart, Ryan J Sullivan, Elizabeth Barksdale, Wendy Selig, Gina Fusaro, Damla Gunenc, Dena Battle, Robyn Burns, Marc S Hurlbert
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 5 (2023)
With multiple PD-(L)1 inhibitors approved across dozens of indications by the US Food and Drug Administration, the number of patients exposed to these agents in adjuvant, first-line metastatic, second-line metastatic, and refractory treatment setting
Externí odkaz:
https://doaj.org/article/48319baa5c5a4d68b9c0d564b37e5e92
Autor:
Laura C Cappelli, Clifton O Bingham, Patrick M Forde, Evan J Lipson, Megan Schollenberger, Ami A Shah, Julie Brahmer, Valsamo Anagnostou, Erika Darrah, Jennifer Mammen
Publikováno v:
RMD Open, Vol 8, Iss 2 (2022)
Objective Patients with inflammatory arthritis (IA) associated with immune checkpoint inhibitor (ICI) treatment for cancer are typically seronegative for anti-cyclic citrullinated peptide (CCP) antibodies and rheumatoid factor, but little is known ab
Externí odkaz:
https://doaj.org/article/aa475359aeb14e71bd548041dbec971e
Autor:
John Wright, Patrick M Forde, Robert L Ferris, Ahmad A Tarhini, Kathleen N Moore, Jennifer R Eads, Valerie Tatard-Leitman
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 8 (2022)
Definitive management of locoregionally advanced solid tumors presents a major challenge and often consists of a combination of surgical, radiotherapeutic and systemic therapy approaches. Upfront surgical treatment with or without adjuvant radiothera
Externí odkaz:
https://doaj.org/article/0837f91f0af34ef39b6c5c784cd6e2a9
Autor:
Jiajia Zhang, Julie R Brahmer, Patrick M Forde, Tanguy Seiwert, Valsamo Anagnostou, Samuel Rosner, Victor E Velculescu, James R White, Joshua E Reuss, Gavin Pereira, Vincent Lam, Christine Hann, Michael Hwang, Kristen Marrone, Kellie N Smith, Joseph C Murray, Jamie E Chaft, Lavanya Sivapalan, Jenna Vanliere Canzoniero, Guangfan Zhang, Zineb Belcaid, Christopher Cherry, Archana Balan, Alexandria Curry, Noushin Niknafs, Qing Kay Li, Benjamin P Levy
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 6 (2022)
Externí odkaz:
https://doaj.org/article/da2666dd4bbf43a0ba1fac37b8c8e007
Autor:
Raffit Hassan, Patrick M Forde, Edward B Garon, Steven M Dubinett, Roy S Herbst, Charu Aggarwal, Matthew D Hellmann, Sarah B Goldberg, David L Rimm, Sarah Sagorsky, Boris Sepesi, Ramaswamy Govindan, Andrea Ferris, Scott J Antonia, Fred R Hirsch, Lawrence H Schwartz, Marianne Davies, Melissa L Johnson, Shakun Malik, Daniel Morgensztern, Joel W Neal, Jyoti D Patel
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 5 (2022)
Immunotherapy has transformed lung cancer care in recent years. In addition to providing durable responses and prolonged survival outcomes for a subset of patients with heavily pretreated non-small cell lung cancer (NSCLC), immune checkpoint inhibito
Externí odkaz:
https://doaj.org/article/a7041ff7bb174ceaaf1394ae132d1c32
Autor:
Chris Brown, Nick Pavlakis, Patrick M Forde, Julie Brahmer, Suresh Ramalingam, Valsamo Anagnostou, Brett Hughes, Martin Stockler, Anna K Nowak, Sonia Yip, Peey Sei Kok, Zhuoxin Sun, Alistair Cook, Willem Joost Lesterhuis, Ken O’Byrne, Kate Ford, Karen Fitzpatrick, Alison Bricker, Michelle M Cummins
Publikováno v:
BMJ Open, Vol 12, Iss 1 (2022)
Externí odkaz:
https://doaj.org/article/e21540c2280a40fb99d2232d875730ae